For patients with colon cancer, structured exercise did make a difference to survival, a trial of nearly 900 people in Canada ...

Patients with newly diagnosed gastric or gastroesophageal junction (GEJ) cancer who received the PD-L1 inhibitor durvalumab ...

Three biomedical research projects conducted NCSU Wilson College of Textiles researchers demonstrate advances in health care ...

"There’s an alchemy that takes place in gratitude, acceptance, meditation, and the frequency of love. It makes a difference." ...

Amgen's Nplate, which treats low blood platelet counts caused by an autoimmune condition, was highly effective at preventing ...

Team awarded $2.5 million grant to develop system for inserting tiny light-emitting fibers directly into tumors.

New research from the University of California, San Francisco (UCSF) has found that certain bacteria living in the human gut ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Published in Brain, Behavior and Immunity—is the first to suggest that a tumor-driving gene known as AEG-1 actively regulates ...

There may be a strategy that regulates inflammation responsible for causing nerve pain due to chemotherapy-induced side effects of treatment, according to research from Virginia Commonwealth ...

Survival benefits of fluoropyrimidine chemotherapy significantly outweighed the risks for cardiovascular events for patients ...

The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy.